ArrePath

Private

Princeton, New JerseyHealthcare & Life Scienceshttps://arrepath.com/

Last Round

VC Round

Jun 23, 2025

Total Funding Raised

$24.97M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ArrePath is a biotechnology company that operates a drug discovery platform intended to develop antimicrobial resistance therapies.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share, Services & Consulting

AI Layer

Application

Keywords

AI drug discoveryantimicrobial resistanceAMRdrug discovery platformanti-infectivesnovel antibioticsAI biotechGram-negative bacteriaAI for drug discoverysmall molecule discoverymechanism of actionmulti-drug resistant infectionsbacterial autopsiesdrug candidate licensingbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ArrePath Comps

Public and private peers based on sector, stage, and business model.

ArrePath comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ArrePath Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Jun 23, 2025
Grant	Apr 2, 2025
Grant	Nov 19, 2024
Seed	Mar 3, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Kurt Thorn

Chief Technology Officer

Executive Team

ArrePath Investors

Notable investors and investment history

ArrePath investors
Investor	Rounds
PTX Capital	Seed
Nor'easter Ventures	VC Round, Seed
Boehringer Ingelheim	VC Round, Seed
PACE (Pathways to Antimicrobial Clinical Efficacy)	Grant
CARB-X	Grant
Viva BioInnovator	Seed
Ab Magnitude Ventures Group	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 16, 2026
Monthly visitors increased 138% MoM.
Jan 22, 2026
Monthly visitors increased 35% MoM.

View all signals

ArrePath Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ArrePath Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ArrePath's valuation, stock price, and market status.

Firmographic Details

HeadquartersPrinceton, New Jersey

Employee Range17

Year Founded2021

Last FundingJun 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.